Trial NCT01118013

View at ClinicalTrials.gov 
Org. Study IDs: CALGB-100601
Secondary IDs: CALGB-100601 CDR0000667954

Last trial update was posted on 2017-03-24

MeSH Interventions

Antilymphocyte Serum Busulfan Fludarabine Fludarabine phosphate Methotrexate Mycophenolic Acid Tacrolimus

MeSH Conditions

Leukemia Lymphoma Lymphoproliferative Disorders Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Myeloproliferative Disorders Neoplasms Neoplasms, Plasma Cell Plasmacytoma Preleukemia Syndrome

Other Conditions

Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic/Myeloproliferative Neoplasms

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID